Latest filing published 19 Aug 2019 for NEKTAR THERAPEUTICS, €62k.
Filing timeline
BuySaleInsider track record
John Nicholson: trading record in brief
John Nicholson discloses dealings in Nektar Therapeutics to SEC (Form 4). We count 48 filings; the first trade dates from 12 March 2009 and the latest from 16 August 2019.
On the market, this insider has only sold: 24 sales, €27.7M in total. Outside the open market, there are 5 share grants and 17 option exercises. In 2019 alone, the filings show no purchases and 4 sales.
On 19 August 2019 came the latest disclosure, an open-market sale for €62k in Nektar Therapeutics. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to John Nicholson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,819 shares@ US$18.151.5% of flowCommon StockSEC:0001209191-19-046718:0
- 4,077 shares@ US$31.372.7% of flowCommon StockSEC:0001209191-19-031188:0
- 3,822 shares@ US$42.392.5% of flowCommon StockSEC:0001209191-19-012335:0
- 63,000 shares@ US$10.692.5% of flowCommon StockSEC:0001209191-19-006044:0
- 63,000 shares@ US$42.8210.1% of flowCommon StockSEC:0001209191-19-006044:1
- 5,982 shares@ US$38.250.8% of flowCommon StockSEC:0001209191-18-059293:0
- 26,000 shares0Common StockSEC:0001209191-18-047242:0
- 8,137 shares@ US$58.401.7% of flowCommon StockSEC:0001209191-18-047242:1
- 4,917 shares@ US$83.391.2% of flowCommon StockSEC:0001209191-18-031596:0
- 120,000 shares@ US$98.2933.6% of flowCommon StockSEC:0001209191-18-018221:0
- 100,144 shares@ US$100.4528.4% of flowCommon StockSEC:0001209191-18-018221:1
- 4,879 shares@ US$82.941.1% of flowCommon StockSEC:0001209191-18-011595:0
- 120,000 shares@ US$11.343.8% of flowCommon StockSEC:0001209191-18-007139:0
- 26,000 shares0Common StockSEC:0001209191-17-066481:0
- 20,000 shares0Common StockSEC:0001209191-17-061594:0
- 6,620 shares@ US$44.230.9% of flowCommon StockSEC:0001209191-17-061594:1
- 25,000 shares@ US$9.240.7% of flowCommon StockSEC:0001209191-17-060974:0
- 15,910 shares@ US$37.781.8% of flowCommon StockSEC:0001209191-17-060974:1
- 3,177 shares@ US$19.320.2% of flowCommon StockSEC:0001209191-17-049667:0
- 150,000 shares@ US$6.343.0% of flowCommon StockSEC:0001209191-17-038973:0
- 101,700 shares@ US$19.246.1% of flowCommon StockSEC:0001209191-17-038973:1
- 3,146 shares@ US$19.550.2% of flowCommon StockSEC:0001209191-17-033770:0
- 3,237 shares@ US$13.140.1% of flowCommon StockSEC:0001209191-17-012407:0
- 45,000 shares@ US$4.650.7% of flowCommon StockSEC:0000899243-17-003648:0
- 66,495 shares@ US$4.651.0% of flowCommon StockSEC:0000899243-17-002871:0
25 of 48 declarations
